Study reveals large differences in drug prescriptions for newborns between NICUs

Little is known concerning how extensively drugs are prescribed to newborns in different neonatal intensive care units (NICUs). A new British Journal of Clinical Pharmacology study of nearly 1,500 newborns admitted during 12 months to four different NICUs in The Netherlands found that drug use varies widely.

Cardiovascular and nervous system drugs were most often prescribed off-label in relation to newborns' age, and their prescription was highly variable between NICUs.

"These differences became larger with decreasing postmenstrual age although the proportion of off-label prescriptions in relation to neonatal age decreased," said lead author Dr. Robert Flint, of Erasmus Medical Center—Sophia Children's Hospital in The Netherlands.

The findings indicate that drug research in should have high priority to ensure the use of safe and appropriate drug therapy in such young patients.

Explore further

Making medications safer for newborns

More information: Robert B. Flint et al, Large differences in neonatal drug use between NICUs are common practice: time for consensus?, British Journal of Clinical Pharmacology (2018). DOI: 10.1111/bcp.13563
Provided by Wiley
Citation: Study reveals large differences in drug prescriptions for newborns between NICUs (2018, April 23) retrieved 23 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more